Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Journal of Autoimmunity
|
June 1, 1993
Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome
R Maran, M Dueymes, Y L Pennec, et al.
Journal of Autoimmunity
|
June 1, 1992
Galactose terminating oligosaccharides of IgG in patients with primary Sjögren's syndrome
P Youinou, Y L Pennec, R Casburn-Budd, et al.
Glycoconjugate Journal
|
August 1, 1996
Aberrant glycosylation of IgA from patients with IgA nephropathy
D Baharaki, M Dueymes, R Perrichot, et al.
Journal of Clinical & Laboratory Immunology
|
June 1, 1990
Treatment of end stage MRL-1pr/lpr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin A
S In, M Dueymes, S Appolinaire-Pilipenko, et al.
International Immunology
|
July 1, 1997
Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells
C Jamin, R Le Corre, J O Pers, et al.
Clinical Neuropharmacology
|
January 1, 1986
Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine
J F Demonet, M Rostin, J M Dueymes, et al.
Clinical and Experimental Immunology
|
July 27, 2001
Functional heterogeneity of anti-endothelial cell antibodies
A Bordron, R Révélen, F D'Arbonneau, et al.
European Journal of Clinical Pharmacology
|
January 1, 1987
Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency
V Rovei, G Campistron, J M Dueymes, et al.
Annales De Medecine Interne
|
January 1, 1987
[Current prognosis of multiple myeloma with renal failure]
M Hemery, J M Dueymes, I Vernier, et al.
International Journal of Immunopharmacology
|
January 1, 1986
Polyclonal activation of lymphocytes induced in the mouse by acebutolol, a beta blocking agent
S In, M Dueymes, G J Fournié, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Journal of Autoimmunity
|
June 1, 1993
Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome
R Maran, M Dueymes, Y L Pennec, et al.
Journal of Autoimmunity
|
June 1, 1992
Galactose terminating oligosaccharides of IgG in patients with primary Sjögren's syndrome
P Youinou, Y L Pennec, R Casburn-Budd, et al.
Glycoconjugate Journal
|
August 1, 1996
Aberrant glycosylation of IgA from patients with IgA nephropathy
D Baharaki, M Dueymes, R Perrichot, et al.
Journal of Clinical & Laboratory Immunology
|
June 1, 1990
Treatment of end stage MRL-1pr/lpr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin A
S In, M Dueymes, S Appolinaire-Pilipenko, et al.
International Immunology
|
July 1, 1997
Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells
C Jamin, R Le Corre, J O Pers, et al.
Clinical Neuropharmacology
|
January 1, 1986
Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine
J F Demonet, M Rostin, J M Dueymes, et al.
Clinical and Experimental Immunology
|
July 27, 2001
Functional heterogeneity of anti-endothelial cell antibodies
A Bordron, R Révélen, F D'Arbonneau, et al.
European Journal of Clinical Pharmacology
|
January 1, 1987
Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency
V Rovei, G Campistron, J M Dueymes, et al.
Annales De Medecine Interne
|
January 1, 1987
[Current prognosis of multiple myeloma with renal failure]
M Hemery, J M Dueymes, I Vernier, et al.
International Journal of Immunopharmacology
|
January 1, 1986
Polyclonal activation of lymphocytes induced in the mouse by acebutolol, a beta blocking agent
S In, M Dueymes, G J Fournié, et al.
Page
of 8